コンテンツへスキップ
Merck
  • The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.

The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.

Colloids and surfaces. B, Biointerfaces (2013-01-10)
Kofi Asare-Addo, Waseem Kaialy, Marina Levina, Ali Rajabi-Siahboomi, Mohammed U Ghori, Enes Supuk, Peter R Laity, Barbara R Conway, Ali Nokhodchi
要旨

Theophylline extended release (ER) matrices containing hypromellose (hydroxypropyl methylcellulose (HPMC) E4M and K4M were evaluated in media with a pH range of 1.2-7.5, using an automated USP type III, Bio-Dis dissolution apparatus. The objectives of this study were to evaluate the effects of systematic agitation, ionic strength and pH on the release of theophylline from the gel forming hydrophilic polymeric matrices with different methoxyl substitution levels. Tribo-electric charging of hypromellose, theophylline and their formulated blends containing E4M and K4M grades has been characterised, along with quantitative observations of flow, compression behaviour and particle morphology. Agitations were studied at 5, 10, 15, 20, 25, 30 dips per minute (dpm) and also in the ascending and descending order in the dissolution vials. The ionic concentration strength of the media was also varied over a range of 0-0.4M to simulate the gastrointestinal fed and fasted states and various physiological pH conditions. To study the effect of ionic strength on the hydrophilic matrices, agitation was set at 20 dpm. The charge results on individual components imply that the positively charged particles have coupled with the negatively charged particles to form a stable ordered mixture which is believed to result in a more homogeneous and stable system. The particle shape analysis showed the HPMC K4M polymer to have a more irregular morphology and a rougher surface texture in comparison to the HPMC E4M polymer, possibly a contributory factor to the gelation process. The results showed gelation occurred quicker for the K4M tablet matrices. Drug release increased with increased agitation. This was more pronounced for the E4M tablet matrices. The ionic strength also had more of an effect on the drug release from the E4M matrices. The experiments highlighted the resilience of the K4M matrices in comparison with the E4M matrices. The results thus show that despite similar viscosities of E4M and K4M, the methoxyl substitution makes a difference to their control of drug release and as such care and consideration should be given to the choice of polymer used for extended release. The use of systematic change of agitation method and ionic strength may indicate potential fed and fasted effects on drug release from hydrophilic matrices.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
メチルセルロース, viscosity: 4,000 cP
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, viscosity 2,600-5,600 cP, 2 % in H2O(20 °C)(lit.)
Sigma-Aldrich
メチルセルロース, viscosity: 15 cP, BioReagent, suitable for cell culture
Sigma-Aldrich
テオフィリン, anhydrous, ≥99%, powder
Sigma-Aldrich
メチルセルロース, viscosity: 1,500 cP
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, average Mn ~10,000
Sigma-Aldrich
メチルセルロース, viscosity: 15 cP
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, viscosity 40-60 cP, 2 % in H2O(20 °C)(lit.)
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, viscosity 80-120 cP, 2 % in H2O(20 °C)(lit.)
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, average Mn ~86,000
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, average Mn ~120,000
Sigma-Aldrich
メチルセルロース, viscosity: 25 cP
Sigma-Aldrich
(ヒドロキシプロピル)メチルセルロース, average Mn ~90,000
Sigma-Aldrich
ヒプロメロース, meets USP testing specifications
Sigma-Aldrich
メチルセルロース, 27.5-31.5% (Methoxyl content), viscosity: 400 cP
Sigma-Aldrich
Methocel® A15 LV, 27.5-31.5% methoxyl basis
Supelco
テオフィリン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Methocel® A4M, viscosity 3000-5500 mPa.s, 2 % in H2O(20 °C)
Sigma-Aldrich
メチルセルロース, meets USP testing specifications, 26.0-33.0% (methoxyl group, on Dry Basis), viscosity: 400 cP
Sigma-Aldrich
Methocel® A15C, medium viscosity, Methoxyl content 27.5-31.5 %
テオフィリン, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
メチルセルロース, 26.0-33.0% (Methoxy group (dry basis)), meets USP testing specifications, viscosity: 1,500 cP
Sigma-Aldrich
メチルセルロース, tested according to Ph. Eur.